ESC: 6-Month DAPT Non-Inferior to Longer Tx Strategy

(MedPage Today) -- But problems with NIPPON trial highlight challenges of dual antiplatelet therapy research
Source: MedPage Today Meeting Coverage - Category: Journals (General) Source Type: news
More News: General Medicine